Landos Biopharma Cash from Investing (TTM) Analysis

Landos Biopharma Inc (LABP)

22.46 +0.16 (+0.72%) USD | NASDAQ | May 17, 16:00

22.46 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	4.671M
December 31, 2023	7.775M
September 30, 2023	19.18M
June 30, 2023	35.76M
March 31, 2023	57.66M
December 31, 2022	74.06M
September 30, 2022	64.38M

Date	Value
June 30, 2022	58.00M
March 31, 2022	32.85M
December 31, 2021	-58.71M
September 30, 2021	-53.57M
June 30, 2021	-60.94M
March 31, 2021	-59.62M
December 31, 2020	14.13M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-60.94M

Minimum

Jun 2021

74.06M

Maximum

Dec 2022

9.688M

Average

16.66M

Median

Cash from Investing (TTM) Benchmarks